Hantaviruses are rodent-borne viruses capable of causing human disease. The Seoul virus is a hantavirus that causes hemorrhagic fever with renal syndrome in East Asia. To our knowledge, we report the first domestically acquired case of hemorrhagic fever with renal syndrome caused by the Seoul virus, confirmed by serology testing, reverse-transcriptase polymerase chain reaction, and nucleotide sequence analysis. The patient presented with myalgias and fever, and developed acute renal failure.
acterized by fever, shock, and renal failure [4] . Sigmodontinaeand Neotominae-associated viruses, enzootic to the Americas, can cause hantavirus pulmonary syndrome, which is characterized by fever, cardiac insufficiency, and pulmonary capillary leakage, often resulting in shock and death [5] . The type and severity of the syndromes vary with the causative virus. Different viruses are linked to each of the syndromes. The Sin Nombre virus is the main cause of hantavirus pulmonary syndrome in North America, with the majority of cases occurring in the western United States. HFRS is caused by multiple viruses, including the Hantaan virus and the Seoul virus in East Asia and the Dobrava virus in continental Europe extending into the Balkan states. Nephropathia epidemica is caused by the Puumala virus in Scandinavia, Russia, and several western European countries. The Seoul virus is associated with Rattus norvegicus (Norway rat), which is distributed worldwide. To our knowledge, we report the first confirmed human case of domestically acquired Seoul virus causing HFRS in the United States.
Case report. In January 2008, a 22-year-old African American man presented to an emergency department complaining of 3 days cough and fever. His pulmonary exam was notable for expiratory wheezing. He received nebulized bronchodilators and was discharged home. Three days later, he returned complaining of nausea, vomiting, crampy abdominal pain, diarrhea, headache, and sore throat, in addition to persistent fever and nonproductive cough. He also reported dark urine and diffuse muscle aches.
His past medical history was notable for well-controlled asthma. The patient lived in the Maryland and worked as a security officer at a shopping mall. He never traveled beyond his residential region.
In the emergency department, the patient was in no apparent distress but appeared ill. He had an oral temperature of 38.56ЊC (101.4ЊF), a pulse rate of 104 beats/minute, and a respiratory rate of 20 breaths/minute. His blood pressure was 96/61 mm Hg, and the oxygen saturation on room air was 98%. He did not have any jaundice, edema, or petechiae, but he did have bilateral conjunctival injection. He was breathing comfortably with no wheezes, rales, or rhonchi. His abdomen was soft and without soreness. His neurologic examination was notable for generalized weakness. He denied muscle tenderness to palpation.
A laboratory evaluation, on the third day of symptoms (Table  1) , revealed leukocytosis with bandemia, thrombocytopenia, hyponatremia, and elevated transaminase, creatinine, and creatinine phosphokinase levels. Radiography and computed tomography revealed no evidence of lung disease. Tests for influenza, parainfluenza, and respiratory syncytial virus were negative. Hospital course. In the emergency department, the patient became hypotensive and was admitted to the medical intensive care unit for fluid resuscitation and vasopressor therapy. He was treated empirically with intravenous ceftriaxone and ciprofloxacin. Urine, serial aerobic, anaerobic, and fungal blood culture results were negative. Serologic tests for Epstein-Barr virus, herpes simplex virus, human immunodeficiency virus, Leptospira interrogans, Coxiella burnetti, Mycoplasma pneumonia, Rickettsia rickettsii, and urinary Legionella pneumophila serogroup 1 were negative. On the sixth day of symptoms, the patient had decreased urinary output with acute renal failure (creatinine level, 12.3 mg/dL), and hemodialysis was initiated. The findings of a renal ultrasound were unremarkable. Given the patient's persistently elevated serum creatinine phosphokinase level and the detection of myoglobinuria, his renal failure was attributed to rhabdomyolysis. He required a total of 6 hemodialysis treatments.
The patient's job included patrolling an underground service tunnel. Coworkers had reportedly seen rodents in this tunnel, although he had not. He denied contact with rodents and could identify no other sources of rodent exposure. Because of the sudden onset of febrile illness and possible rodent exposure, hantavirus pulmonary syndrome was considered. The patient was discharged 29 days after symptom onset, with a serum creatinine level of 1.5 mg/dL; all other laboratory test results had returned to baseline.
Public health officials could not elicit a clear history of rodent exposure from the patient. An environmental assessment of the patient's home did not reveal rodent infestation. An assessment of the patient's workplace revealed an environment hospitable to rodents (because of the presence of open, seeping garbage bags) and the possible presence of rodents (because of the presence of rodent droppings and bait boxes). One night of rat trapping at the patient's home and workplace did not result in any rats being trapped. Among the patient's coworkers and housemates, there were no reports of similar illness.
Discussion. Human disease attributable to the Seoul virus occurs in East Asia, with the majority of cases occurring in Korea, China, Russia, and Japan [6] . This virus causes a milder form of HFRS than does the Hantaan virus (the primary etiologic agent of HFRS in East Asia) or the Dobrava virus (the primary etiologic agent of HFRS in the Balkan countries) [7] . In a description of 40 cases of HFRS caused by the Seoul virus, Lee [2] reported that most of the patients presented with abrupt onset of fever, chills, and weakness, followed by anorexia, myalgias, and headache. This was usually followed by development of nausea, vomiting, and abdominal pain. The most common laboratory findings among these patients included leukocytosis with left shift, presence of atypical lymphocytes, thrombocytopenia, azotemia, and transaminitis. A relatively moderate course is characteristic of Seoul virus-induced HFRS.
To our knowledge, no prior published reports of HFRS caused by the Seoul virus have noted elevated creatinine phosphokinase levels or the presence of rhabdomyolysis; however, rhabdomyolysis has been documented to occur in cases of HFRS as a result of the Hantaan virus [8] or the Puumala virus [9] . Whether this is an anomalous finding or a rare complication of HFRS caused by Seoul virus infection is unclear. In a study reported by Kim et al [10] , 30 patients with HFRS secondary to Seoul virus had a median creatinine phosphokinase level of 81 IU/L (range, 8-3639 IU/L). Kim et al [10] did not comment on whether any of the patients had clinical rhabdomyolysis.
Previously published studies on the prevalence of the Seoul virus antibody report evidence of exposure among the rat and human populations in the United States, Canada, Brazil, and Argentina [11] [12] [13] [14] [15] [16] . Prevalence studies of Norway rats in Baltimore revealed that 150% of the rats had serologic evidence of exposure to the Seoul virus [11] . A subsequent study of blood samples submitted to a Baltimore hospital revealed that 22 (1.64%) of 1341 of patients with proteinuria exceeding 250 mg/24 h had neutralizing antibodies to the Seoul virus [17] . This indicates previous infection with the Seoul virus but does not establish a causative relationship between the Seoul virus and the development of proteinuria. This study [17] also retrospectively described 3 cases of a syndrome consistent with HFRS that had serologic evidence of recent Seoul virus infection (ie, a 4-fold increase in neutralizing antibody titer by use of the plaque-reduction neutralization test).
A cross-sectional study by Glass et al [18] comparing subjects with end-stage renal disease (ESRD) or proteinuria with a reference group of Baltimore residents indicated that the reference group had an overall prevalence of neutralizing antibodies to the Seoul virus of 0.25%, which was significantly different from the seroprevalence of 2.80% among those with ESRD and the seroprevalence of 1.46% among those with proteinuria, when adjusted for age. Among those with ESRD, subjects with hypertension had a significantly higher prevalence of neutralizing antibodies to the Seoul virus (6.5%), compared with patients with ESRD who were not hypertensive. This study [18] suggests that Seoul virus infection may have an association with hypertensive renal disease. Finally, in a study of 635 intravenous drug users in Baltimore, 1 (0.16%) had evidence of past infection with the Seoul virus, as demonstrated by the presence of anti-Seoul virus IgG antibody [19] .
Although Seoul virus causing HFRS has been reported in East Asia and, retrospectively, cases have been suggested to have occurred in the United States, to our knowledge, our report represents the first confirmed case of Seoul virus infection in the United States. The documented presence of the Seoul virus among urban rat populations as well as prior studies documenting Seoul virus antibodies among subjects in the United States indicate the importance of considering this diagnosis among patients with a history of rat exposure who present with acute renal failure accompanied by fever and gastrointestinal signs and symptoms.
